NuVasive received FDA clearance for magnetic resonance imaging under certain conditions on patients treated with the MAGEC® growth modulation system.
Under the scan conditions defined, the system is expected to produce a maximum temperature rise of no more than 3.7 degrees Celsius after 15 minutes of continuous scanning.
MAGEC is the only magnetically-controlled growth modulation system cleared by FDA for the treatment of pediatric spinal deformity. In mid-3Q16, CMS granted a new technology add-on payment for magnetically-controlled growth rods.
NuVasive received FDA clearance for magnetic resonance imaging under certain conditions on patients treated with the MAGEC® growth modulation system.
Under the scan conditions defined, the system is expected to produce a maximum temperature rise of no more than 3.7 degrees Celsius after 15 minutes of continuous scanning.
MAGEC is the only...
NuVasive received FDA clearance for magnetic resonance imaging under certain conditions on patients treated with the MAGEC® growth modulation system.
Under the scan conditions defined, the system is expected to produce a maximum temperature rise of no more than 3.7 degrees Celsius after 15 minutes of continuous scanning.
MAGEC is the only magnetically-controlled growth modulation system cleared by FDA for the treatment of pediatric spinal deformity. In mid-3Q16, CMS granted a new technology add-on payment for magnetically-controlled growth rods.
Copy to clipboard 
